(S1 (S (NP (NP (NP (VBN Increased) (NN p21) (NN expression)) (CC and) (NP (NN complex) (NN formation))) (PP (IN with) (NP (NN cyclin) (NN E/CDK2))) (PP (IN in) (NP (JJ retinoid-induced) (JJ pre-B) (NN lymphoma) (NN cell) (NN apoptosis))) (. .))))
(S1 (S (S (NP (NP (NN Cip/Kip) (NN family) (NN protein) (NN p21)) (, ,) (NP (DT a) (NP (NP (JJ cyclin-dependent) (NN kinase)) (PRN (-LRB- -LRB-) (NP (NN CDK)) (-RRB- -RRB-))) (NN inhibitor)) (, ,)) (VP (VBZ is) (ADVP (RB directly)) (VP (VBN transactivated) (PP (IN by) (NP (NP (JJ retinoic) (NN acid) (NN receptor) (NN alpha)) (PRN (-LRB- -LRB-) (NP (NN RARalpha)) (-RRB- -RRB-)))) (PP (IN upon) (NP (NP (JJ retinoic) (NN acid)) (NN -LRB-RA-RRB-:RARalpha) (NN binding)))))) (. .)))
(S1 (S (S (CC Yet) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NP (NN p21) (NN upregulation)) (PP (IN by) (NP (NN RA))))) (PP (IN in) (NP (NN lymphoma) (NNS cells)))) (VP (VBZ remains) (ADJP (JJ unknown)))) (. .)))
(S1 (S (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (, ,) (PP (IN in) (NP (JJ human) (JJ pre-B) (NN lymphoma) (NN Nalm6) (NNS cells))) (, ,) (NP (JJ RA-induced) (NN proliferation) (NN inhibition)) (VP (VBZ results) (PP (IN from) (NP (NP (JJ massive) (NN cell) (NN death)) (VP (VBN characterized) (PP (IN by) (NP (NN apoptosis))))))))))) (. .)))
(S1 (S (S (NP (NP (VBN Upregulated) (NN p21)) (PP (IN by) (NP (NN RA)))) (VP (VP (VBZ accompanies) (NP (NN caspase-3) (NN activation))) (CC and) (VP (VBZ precedes) (NP (NP (DT the) (NN occurrence)) (PP (IN of) (NP (NN apoptosis))))))) (. .)))
(S1 (S (S (NP (NN p21) (NN induction)) (VP (VBZ leads) (PP (TO to) (NP (NP (VBN increased) (NN p21) (NN complex) (NN formation)) (PP (IN with) (NP (NN cyclin) (NN E/CDK2))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ occurs) (SBAR (WHADVP (WRB when)) (S (NP (NP (NP (NN cyclin) (NN E)) (CC and) (NP (NN CDK2))) (NNS levels)) (VP (VBP remain) (ADJP (JJ constant)))))))))))) (. .)))
(S1 (S (S (S (NP (NN CDK2)) (VP (MD can) (ADVP (RB alternatively)) (VP (VB promote) (NP (NN apoptosis))))) (, ,) (CC but) (S (NP (DT the) (NNS mechanisms)) (VP (VBP remain) (ADJP (JJ unknown))))) (. .)))
(S1 (S (S (NP (NP (NNS Data)) (VP (VBN presented) (ADVP (RB here)))) (VP (VBP suggest) (NP (NP (DT a) (JJ novel) (NN RA-signaling)) (, ,) (SBAR (WHPP (IN by) (WHNP (WDT which))) (S (NP (NP (NP (JJ RA-induced) (NN p21) (NN induction)) (CC and) (NP (NN complex) (NN formation))) (PP (IN with) (NP (NN cyclin) (NN E/CDK2)))) (VP (VBZ diverts) (NP (NN CDK2) (NN function)) (PP (IN from) (NP (NP (ADJP (RB normally) (VBG driving)) (NN proliferation)) (PP (TO to) (NP (ADJP (RB alternatively) (VBG promoting)) (NN apoptosis))))))))))) (. .)))
